GSK1940029
new
featured

    WARNING: This product is for research use only, not for human or veterinary use.

MedKoo CAT#: 555378

CAS#: 1150701-66-8

Description: GSK1940029, also known as SCD Inhibitor 1, is a SCD Inhibitor. GSK1940029 is a potential topical treatment of acne,


Price and Availability

Size
Price

5mg
USD 80
50mg
USD 450
500mg
USD 2150
Size
Price

10mg
USD 150
100mg
USD 850
1g
USD 3250
Size
Price

25mg
USD 250
200mg
USD 1250
2g
USD 5650

GSK1940029, purity > 98%, is in stock. The same day shipping after order received


Chemical Structure

img

Theoretical Analysis

MedKoo Cat#: 555378
Name: GSK1940029
CAS#: 1150701-66-8
Chemical Formula: C18H16Cl2N4O2
Exact Mass: 390.065
Molecular Weight: 391.252
Elemental Analysis: C, 55.26; H, 4.12; Cl, 18.12; N, 14.32; O, 8.18


Synonym: GSK1940029; GSK-1940029; GSK 1940029; SCD Inhibitor 1;

IUPAC/Chemical Name: 1-[(3,4-dichlorophenyl)methyl]-N-[4-(hydroxymethyl)phenyl]-5-methyltriazole-4-carboxamide

InChi Key: QQRGSFYTPBYCFD-UHFFFAOYSA-N

InChi Code: InChI=1S/C18H16Cl2N4O2/c1-11-17(18(26)21-14-5-2-12(10-25)3-6-14)22-23-24(11)9-13-4-7-15(19)16(20)8-13/h2-8,25H,9-10H2,1H3,(H,21,26)

SMILES Code: O=C(C1=C(C)N(CC2=CC=C(Cl)C(Cl)=C2)N=N1)NC3=CC=C(CO)C=C3


Technical Data

Appearance:
Solid powder

Purity:
>98% (or refer to the Certificate of Analysis)

Certificate of Analysis:

Safety Data Sheet (MSDS):

Shipping Condition:
Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.

Storage Condition:
Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).

Solubility:
Soluble in DMSO

Shelf Life:
>3 years if stored properly

Drug Formulation:
This drug may be formulated in DMSO

Stock Solution Storage:
0 - 4 C for short term (days to weeks), or -20 C for long term (months).

Harmonized System Code:
2934.99.90.01


References

1: Brigandi RA, Zhu J, Murnane AA, Reedy BA, Shakib S. A Phase 1 Randomized,
Placebo-Controlled Trial With a Topical Inhibitor of Stearoyl-Coenzyme A
Desaturase 1 Under Occluded and Nonoccluded Conditions. Clin Pharmacol Drug Dev.
2019 Apr;8(3):270-280. doi: 10.1002/cpdd.644. Epub 2019 Jan 16. PubMed PMID:
30650256; PubMed Central PMCID: PMC6590436.